Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer. - Makovec A; Boytim E; Gustafson A; Ludwig M; Wang L; Ali A; Ishani K; Luo C; Bergom HE; John E; Tape S; Kellen S; et al. (NPJ precision oncology, 2025)